DOI:
10.1055/s-00000068
Seminars in Interventional Radiology
LinksClose Window
References
Neoptolemos JP, Palmer DH, Ghaneh P. , et al; European Study Group for Pancreatic Cancer.
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.
Lancet 2017;
389 (10073): 1011-1024
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.